Former Lansinoh CEO shifts to Insight Pharmaceuticals

LANGHORNE, Pa. A developer, manufacturer and marketer of OTC consumer brands has appointed a new chief executive.

Insight Pharmaceuticals, maker of such brands as Anacin and Dermarest, announced that Gary Downing will become CEO of the company Feb. 15. Prior to this appointment, Downing served as CEO of breastfeeding product maker Lansinoh for nearly eight years, leading the company's and profitability to grow more than fivefold and sevenfold, respectively. Downing also co-founded niche OTC brand marketing company Medtech, and held senior management positions at such industry leaders as Rhone-Poulene Rorer, Gillette’s Oral-B Labs and Richardson-Vicks, where he had a successful track record of developing profitable businesses.

“We are very excited to have someone of Gary’s caliber joining the Insight team and are looking forward to his leadership and contribution to further the growth of our business.  His background and experience in acquiring and developing brands are a perfect complement to our long-term strategy,” said Mo Stout, Insight Pharmaceuticals chairman.